Angelini Fine Chemicals, business unit of Angelini Pharma S.p.A., is at the forefront of chemical development and third-party cGMP manufacturing of Early & Adv. IMs., APIs and HPAPIs serving the branded pharmaceutical industry. Located in the industrial outskirts of Aprilia (Southern Rome Area, Italy), with over 70.000 m2 cGMP plant facility and cutting-edge 180 m2 R&D labs in just one-site, Angelini Fine Chemicals is housing a wide reaction technology portfolio and scale-up capabilities to meet chemistry outsourcing needs of pharmaceutical industry– from early- / late-stage chemical development runs to PoC batch up to cGMP production of clinical and commercial lots, from 1-1000+kg up to multi-tons scale of product demand.

Angelini Fine Chemicals brings over 50 years of experience in the research and development of chemical process for production of APIs / HPAPIs. Our long industrial history has built up all necessary technical capabilities and process chemistry know-how to carry out scale-up of a wide reaction portfolio. With continuous programs of investments in R&D and novel chemical technologies, Angelini Fine Chemicals offers niche and high-barrier-to-entry technology platforms for a vast range of CDMO services, including HPAPI handling (OEB5 – OEL 1-0,1 µg/m3), chromatography purification (up to commercial scale on 800 L), hydrogenation (up to 25 bar) and flow chemistry capacity (up to commercial scale). Our "make-chemistry" attitude along with the quality and experience of our R&D and technical staff are a valuable tool to pharmaceutical customers seeking an attractive and trustworthy CDMO partner to expediting their R&D pipeline to market.